United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates

Autor: S. Duncil, R. Baumhefner, V. Gausche, L. Tvardek, G. Shifroni, E. Cerreta, S. Remo, J. H. Parnell, D. Lefkowitz, S. J. Bird, L. Needham, B. Borowski, M. Shepard, Y. Stark, S. Craig, L. Pardo, T. Vollmer, E. Katz, G. W. Ellison, C Jr Bever, A. C. Tselis, R. Grossman, P. M. Colletti, S. R. Schwid, I. Pinchasi, M. Singh, Staley A. Brod, W. Badger, Andrew D. Goodman, J. B. Guarnaccia, A. Gudusky, H. Panitch, M. A. Burns, J. Tsuruda, Jerry S. Wolinsky, J. W. Rose, D. Lisak, M. Gorbova, C. J. Becker, L. P. Weiner, E. W C Kwok, Dennis L. Kolson, B. Peters, C. Kawai, J. W. Lindsey, N. Carr, I. Vainrub, R. Misnick, K. McCarthy, R. Lewis, M. D. Petrie, J. Flemming, M. Viswanathan, C. Halvorson, K. P. Johnson, P. Turski, G. Sze, O. Khan, B. R. Brooks, D. Ladkani, D. Pfohl, A. Wallace, K. Martin, A. A. Pruitt, Francisco Gonzalez-Scarano, Ponnada A. Narayana, J. Kamholtz, R. Padilla, R. P. Lisak, L. Mannon, S. Kadosh, C. C. Ford, K. Conway, G. Hunter, S. Bhat, S. Jalbut, L. Medina, L. Rosner, L. W. Myers, G. Moore, J. B. Burns, S. Sinha, E. Greinel, J. Garbern, D. A. Shrier, M. Boykins, J. R. Bentson, N. Kachuck, M. Nessaiver

Publikováno v: Multiple Sclerosis. 7:33-41

After the placebo-controlled extension of the pivotal US trial of glatiramer acetate for the treatment of relapsing multiple sclerosis ended, 208 participants entered an open-label, long-term treatment protocol. Magnetic resonance imaging (MRI) was a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a0a63205d214a1f405d85fd63875403c
https://doi.org/10.1191/135245801667520627

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Autor: E. Greinel, I. H. Gomolin, Jerry S. Wolinsky, Suhayl Dhib-Jalbut, David Ladkani, L. R. Rogers, J. Tamulevich, Yafit Stark, B. Gandhi, Staley A. Brod, J. B. Burns, Dennis L. Kolson, Sara G. Austin, K. A. McCarthy, J. W. Rose, S. J. Bird, E. Cerreta, J. H. Parnell, D. Lisak, Kenneth P. Johnson, S. Van Den Noort, L. Smith, L. Pardo, L. W. Myers, J. Guarnaccia, Hillel Panitch, G. W. Ellison, K. L. Conway, Jonathan Goldstein, Christopher T. Bever, C. C. Ford, Andrew D. Goodman, Timothy Vollmer, I. Pinchasi, OA Khan, G. R. Barger, J. W. Lindsey, S. L. Craig, F. J. Vriesendorp, A. Pruitt, B. R. Brooks, M. D. Petri, A. E. Miller, E. Katz, A. McKeon, J. Fleming, C. Kawai, Francisco Gonzalez-Scarano, C. Weasler, W. Mulcahy, A. B. Thomas, S. Reingold, L. P. Weiner, Cris S. Constantinescu, R. P. Lisak, N. Kachuck, D. Pfohl, R. W. Baumhefner, S. Kadosh, M. Dimachkie, D. Mellits

Publikováno v: Scopus-Elsevier

In a randomized, placebo-controlled, double-blind study, glatiramer acetate (Copaxone®) reduced the relapse rate and slowed accumulation of disability for patients with relapsing-remitting multiple sclerosis. Of the original 251 patients randomized

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ced7b219d8e66817c7bc9a2e3e0fb2c9
https://doi.org/10.1191/135245800678827806

Clinical neurophysiology in the intensive care unit

Autor: C F, Bolton, U, Zifko, S J, Bird

Publikováno v: Supplements to Clinical neurophysiology. 53

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d755e452007d8fe9528397b617d44fe6
https://pubmed.ncbi.nlm.nih.gov/12740974

Acute axonal neuropathy in maple syrup urine disease

Autor: K A, Kleopa, D M, Raizen, C A, Friedrich, M J, Brown, S J, Bird

Publikováno v: Musclenerve. 24(2)

A 25-year-old woman with maple syrup urine disease (MSUD) developed generalized weakness over 1 week. She had severe leg and moderate arm weakness, areflexia, and distal sensory loss. Plasma branched-chain amino acid concentrations were elevated, ref

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f545ae06789a4c2dfef8605f4dfc2f4d
https://pubmed.ncbi.nlm.nih.gov/11180212

Chronic multiple paraneoplastic syndromes

Autor: K A, Kleopa, J W, Teener, S S, Scherer, S L, Galetta, S J, Bird

Publikováno v: Musclenerve. 23(11)

A patient presented with symptoms of limbic and brainstem encephalitis, motor and sensory neuronopathy, cerebellar dysfunction, and highly positive anti-Hu antibodies. He also harbored P/Q-type calcium channel antibodies and manifested the Lambert-Ea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d06def2d72981f8014ba7b390d665e4d
https://pubmed.ncbi.nlm.nih.gov/11054759